Prostate cancer, hormone therapy & fractures
- Tuesday, 22 September 2015
Hormone therapy for prostate cancer puts a man at risk for osteoporosis.
Androgen deprivation therapy (ADT) for prostate cancer puts men at risk for fractures.
Androgens are male hormones. Male hormones spur prostate cancer. Some men with prostate cancer undergo androgen-deprivation therapy (ADT). ADT lowers the production of male hormones, but it increases the risk for bone loss and fractures according to studies, says the National Osteoporosis Foundation. Osteoporosis is when you lose bone and/or make too little bone.
So what’s a man on ADT to do? For beginners, you may want to have a baseline bone density test before you start ADT. If you have low bone density, your physician may want to prescribe a medication for osteoporosis. Perform weight-bearing exercises like walking or lifting weights, and make sure you get enough calcium and Vitamin D. Also avoid smoking and consuming liquor as these activities increase the risk for bone loss. Talk to physician about the best strategies for you if you are on hormone therapy
ED & Prostate Cancer Surgery
- Wednesday, 10 June 2015
Men who undergo a nerve-sparing prostatectomy (prostate removal) by robot-assisted laparascopy may be more likely to regain their erectile function than men who undergo the ‘open’ surgery, say German researchers at the University Hospital Leipzig.
Laparascopic prostate removal is performed through small, keyhole-sized incisions. Traditional ‘open’ prostate removal requires a long incision down the abdomen.
Researchers at the German hospital studied 422 men, 67 years and younger, who had normal erectile function (EF) before their prostatectomy. All the men had localized prostate cancer i.e. the cancer had not spread beyond the prostate gland.
Following surgery, patients in the study received either tadalafil (commonly marketed as Cialis for ED) or a placebo (sugar pill) after surgery for nine months. This period was followed by a six-week drug-free ‘washout.’
Men who had a robot-assisted laparoscopy were 2.4 times more likely to have erectile function recovery at the conclusion of the drug-free washout when compared to the open-surgery group.
A better way to biopsy prostate cancer?
- Tuesday, 17 March 2015
Targeted biopsy allows for more accuracy.
The new method fuses or combines magnetic resonance imaging (MRI) with ‘real-time’ ultrasound. ‘Real-time’ means the image is acquired as the exam is being performed. It’s not a stored image obtained days or weeks earlier.
‘Targeted biopsy’ allows the physician to zero in on suspicious areas as opposed to the traditional, prostate biopsy of random or ‘blind’ tissue sampling. The new method detects prostate cancer with greater accuracy. It also helps to better stage prostate cancer when the disease is detected. This, in turn, can help prostate cancer patients who are considering active surveillance.
Physicians also believe that targeted biopsies will be particularly helpful to men who have persistently high PSA levels but who routinely test negative for prostate cancer.
Tomato-rich diet may help fight prostate cancer
- Tuesday, 16 December 2014
Men who consume more than 10 portions of tomatoes or tomato products per week have an 18 percent lower risk of developing prostate cancers, suggests a recent British study.
Researchers at the universities of Bristol, Cambridge and Oxford examined the lifestyle and diets of approximately 1,800 British men between the ages of 50 and 60 men with cancer and approximately 12,000 men who did not have cancer.
The cancer-fighting ingredient is believed to be lycopene, a powerful antioxidant that gives tomatoes and certain other fruits and vegetables their red color. Although the study’s findings are suggestive, they did not provide enough evidence to make a concrete recommendation.
Baldness & aggressive prostate cancer
- Thursday, 16 October 2014
Men who develop male-pattern baldness— characterized by a receding hairline and thinning hair on the dome of their heads — may be at an increased risk of developing aggressive prostate cancer when they get older, says a new study published in the Journal of Clinical Oncology.
Researchers analyzed the hair-loss patterns of almost 40,000 men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. They discovered that men who had male pattern baldness by age 45 had a 40 percent increased risk of developing aggressive prostate cancer than those men who did not experience male pattern baldness. Researchers suspect the link is due to increased levels of the male sex hormones. More studies are needed.